Westfield Capital Management CO LP Novavax Inc Transaction History

Westfield Capital Management CO LP

  • $21.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$134.56 - $217.97 $32.1 Million - $52 Million
-238,400 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$177.8 - $270.58 $6.21 Million - $9.44 Million
34,900 Added 17.15%
238,400 $49.4 Million
Q2 2021

Aug 10, 2021
BUY
$121.0 - $257.67 $11.8 Million - $25.1 Million
97,491 Added 91.96%
203,500 $43.2 Million
Q1 2021

May 14, 2021
BUY
$112.98 - $319.93 $12 Million - $33.9 Million
106,009 New
106,009 $19.2 Million

Others Institutions Holding NVAX

# of Institutions
290
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email